Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabetes and the WHO Model List of Essential Medicines.
Beran D, Besançon S, Ewen M, Gale EAM, Lazo-Porras M, Lepeska M, Lipska K, Zafra-Tanaka J, Zhaparova A, Yudkin JS. Beran D, et al. Among authors: lepeska m. Lancet Diabetes Endocrinol. 2022 Jan;10(1):17-18. doi: 10.1016/S2213-8587(21)00323-5. Lancet Diabetes Endocrinol. 2022. PMID: 34919864 No abstract available.
Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.
Abdraimova A, Besançon S, Portocarrero J, Ramaiya K, Dunganova A, Ewen M, Hogerzeil H, Lazo-Porras M, Laing R, Lepeska M, Nchimbi H, Sidibé A, Swai A, Tenorio-Mucha J, Yudkin JS, Zafra-Tanaka JH, Zurdinova A, Beran D. Abdraimova A, et al. Among authors: lepeska m. Diabet Med. 2022 Aug;39(8):e14891. doi: 10.1111/dme.14891. Epub 2022 Jun 6. Diabet Med. 2022. PMID: 35621029 Free PMC article.
User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.
Safary E, Beran D, Vetter B, Lepeska M, Abdraimova A, Dunganova A, Besançon S, Lazo-Porras M, Portocarrero Mazanett J, Pérez-León S, Maixenchs M, Nchimbi H, Ramaiya K, Munishi C, Martínez-Pérez GZ. Safary E, et al. Among authors: lepeska m. BMJ Open. 2024 Feb 17;14(2):e076685. doi: 10.1136/bmjopen-2023-076685. BMJ Open. 2024. PMID: 38367964 Free PMC article.
Teplizumab approval for type 1 diabetes in the USA.
Beran D, Abidha C, Adler A, de Beaufort C, Lepeska M, Levitt N, Pfiester E, Zafra-Tanaka JH, Gale EA. Beran D, et al. Among authors: lepeska m. Lancet Diabetes Endocrinol. 2023 Feb;11(2):78-80. doi: 10.1016/S2213-8587(22)00384-9. Epub 2023 Jan 6. Lancet Diabetes Endocrinol. 2023. PMID: 36623522 No abstract available.